Summary. The effect of acid-base balance on the oxidation and utilization of citrate and other organic acids has been studied in tissue slices and isolated kidney mitochondria. The results show that: 1) With bicarbonate-buffered media, citrate oxidation and utilization are inhibited in slices of renal cortex and in kidney mitochondria when [HCO3-] and pH are increased within the physiologic range (pH 7.0 to 7.8; 10 to 60 tumoles HCO3-per ml). When phosphate or Tris buffers are used, no comparable effect on citrate oxidation occurs when pH is varied. 2) This effect is not demonstrable in heart or liver slices when a physiologic buffer is used. 3) a-Ketoglutarate utilization is inhibited in slices of renal cortex under similar conditions. Pyruvate and L-malate utilization are not inhibited in slices or mitochondria. 4) Citrate content in slices of renal cortex incubated with a high [HCO3-] is considerably greater than the concentration found with a low [HCO3-] in the medium. This effect is not duplicated by pH change in a nonbicarbonate buffer system. In mitochondria citrate content is also increased markedly at high bicarbonate concentrations. 5) The kinetic characteristics of the inhibition of citrate oxidation are those of a competitive type of inhibition. 6) When pH was varied with a constant [HCO3-] in the media, citrate oxidation was inhibited by increasing pH in slices of renal cortex but not in mitochondria. On the other hand, when [HCO3-] was increased without change in pH, no decrease in citrate oxidation occurred in slices, but a marked inhibitory effect was found when mitochondria were used.
Summary. The effect of acid-base balance on the oxidation and utilization of citrate and other organic acids has been studied in tissue slices and isolated kidney mitochondria. The results show that: 1) With bicarbonate-buffered media, citrate oxidation and utilization are inhibited in slices of renal cortex and in kidney mitochondria when [HCO3-] and pH are increased within the physiologic range (pH 7.0 to 7.8; 10 to 60 tumoles HCO3-per ml). When phosphate or Tris buffers are used, no comparable effect on citrate oxidation occurs when pH is varied. 2) This effect is not demonstrable in heart or liver slices when a physiologic buffer is used. 3) a-Ketoglutarate utilization is inhibited in slices of renal cortex under similar conditions. Pyruvate and L-malate utilization are not inhibited in slices or mitochondria. 4) Citrate content in slices of renal cortex incubated with a high [HCO3-] is considerably greater than the concentration found with a low [HCO3-] in the medium. This effect is not duplicated by pH change in a nonbicarbonate buffer system. In mitochondria citrate content is also increased markedly at high bicarbonate concentrations. 5) The kinetic characteristics of the inhibition of citrate oxidation are those of a competitive type of inhibition. 6) When pH was varied with a constant [HCO3-] in the media, citrate oxidation was inhibited by increasing pH in slices of renal cortex but not in mitochondria. On the other hand, when [HCO3-] was increased without change in pH, no decrease in citrate oxidation occurred in slices, but a marked inhibitory effect was found when mitochondria were used.
From a comparison of these results with those previously obtained in intact animal experiments, we conclude that the inhibition of citrate oxidation caused by increasing pH and [HCO,-] in slices of renal cortex and kidney mitochondria is an in vitro representation of the inhibition of citrate reabsorption in the nephron that occurs in metabolic alkalosis. Thus, citrate clearance increases in metabolic alkalosis because of inhibition of oxidation of reabsorbed citrate within cells of the renal tubules. This inhibition is the result of an inhibitory effect of bicarbonate ion on citrate oxidation in mitochondria.
Introduction mals nearly all of the citrate filtered through the The renal clearance of citrate is greatly increased glomerulus is reabsorbed in the nephron with during metabolic alkalosis (1) (2) (3) . In normal ani-only small quantities escaping into the urine. In the presence of metabolic alkalosis the tubular reabsorption of citrate is inhibited, and the excretion of citrate increases manyfold with little concomitant change in the plasma level. The physiologic characteristics of this phenomenon have been described in numerous reports, but the cellular mechanism responsible for it has not been defined.
Three possibilities exist to explain the effect of metabolic alkalosis on citrate clearance. First, secretion of citrate, derived either from renal blood or from synthesis within the cells of the tubules, could be enhanced by metabolic alkalosis, resulting in increased urinary citrate. However, evidence from physiologic studies suggests that secretion of citrate is not primarily responsible for increasing the clearance of citrate in metabolic alkalosis (4) . Second, metabolic alkalosis could inhibit the transport of citrate across cell membranes in the tubules, thus decreasing the reabsorption of citrate. Such an effect would be analogous, for example, to the effect of phlorizin on glucose reabsorption. Third, metabolic alkalosis could increase citrate clearance by inhibiting the intracellular oxidation of citrate. This possibility must be considered because an important characteristic of the renal physiology of citrate is the rapid oxidation of this substance by cells of the cortex. Recently it has been shown that citrate oxidation may account for as much as 10% of the oxygen consumption of the kidney (5) . The consumption of citrate by the kidney normally exceeds the amount of filtered citrate by about one-third (4, 6). Therefore, both reabsorbed citrate and significant amounts of unfiltered citrate from the blood are metabolized in the kidney and provide energy for other renal functions. Thus, the normal fate of reabsorbed citrate is oxidation in the cells of the tubules; interference with this process could decrease the fraction of citrate reabsorbed.
The available data from intact animal studies do not allow a distinction to be made between an effect of metabolic alkalosis on citrate transport and an effect on the intracellular metabolism of citrate. In the present investigation an in vitro system was sought that would permit investigation of the cellular mechanism underlying this effect of metabolic alkalosis. In tissue slices of renal cortex and in kidney mitochondria, increasing pH and bicarbonate concentrations in the medium were found to inhibit citrate oxidation. The properties of this in vitro effect closely resemble those which have previously been described for the effect of metabolic alkalosis on citrate clearance in the intact animal.
Methods
Preparation and incubation of tissue slices. Fresh kidneys obtained from exsanguinated rabbits were placed in ice-cold slicing medium consisting of 0.14 M NaCl and 0.01 M KCl. Slices were cut from pieces of cortex with a Stadie-Riggs-type slicer calibrated to cut slices 0.25 mm thick. After slicing, a group of slices was blotted gently on filter paper and weighed on a torsion balance. Between 190 and 200 mg of slices was used in each flask. The weighed groups of slices were then kept in individual beakers containing ice-cold slicing medium until it was time to place them in the incubation flasks.
The rate of citrate oxidation was determined by measuring the rate of formation of "4CO2 from citrate-1,5-14C. Slices were incubated in Dixon-Keilin-type Warburg vessels (7) . (These flasks are designed for use with a bicarbonate buffer system in which a constant C02 concentration is maintained in the gas phase during incubation. They are constructed with a stopcock on the bottom of each vessel containing a small hollowed-out chamber in which sodium hydroxide solution is placed. During incubation this solution is sealed off from the interior of the flask; at the end of the experiment the stopcock is turned until the stopcock chamber communicates with the center well of the flask and the C02 in the flask is absorbed by the sodium hydroxide solution.) A typical incubation medium contained, per milliliter, 10 /moles NaHCO3, 122 Amoles NaCl, 10 /Amoles KCl, 1 /Amole KH2PO4, 1 Amole Na citrate, 2 Mmoles Na pyruvate, and 2 umoles Na L-malate. We used high medium K+ concentration in order to ensure adequate potassium to replace intracellular losses occurring while the slices were kept in the cold slicing medium. However, the effects to be described can be demonstrated even in the absence of potassium in the medium. Organic acid solutions were adjusted to pH 7.2 to 7.4 before being added to the medium. Variations in the composition of the medium were compensated for by increasing or decreasing the amount of NaCl as necessary to keep the osmolarity of the medium constant. We placed 1.8 ml of medium in each flask and 0.5 ml 1 N HCl in the sidearm. The stopcock chamber was filled with 6 N NaOH and closed; a strip of filter paper was placed in the center well. We placed 25 /Al of radioactive citrate solution in a microvessel attached to the inside wall of the Warburg flask with a small drop of paraffin. Before the slices were placed in the flasks the latter were warmed in a Warburg bath to 300 C and gassed with 5% COY95%o 02. In some experiments we used other concentrations of C02 in order to vary the C02 tension in the medium. Before passing through the flasks, gas mixtures were saturated with water vapor. After equilibrium with the gas mixture was obtained, the tissue slices were added and the gassing continued for 5 minutes. The flask vents were then closed and the radioactive citrate released into the medium by gently melting the paraffin holding the microvessel to the flask wall. The slices were incubated with the radioactive substrate for 15 minutes at 300 C and the experiment stopped by tipping acid in from the sidearm. The stopcock on the bottom of the flask was turned until the chamber within it was under the center well of the flask, allowing the NaOH solution to wet the filter paper. Shaking of the flask was continued for 2 hours while the C02 was being absorbed. Control observations indicated that all of the C02 in the flasks was absorbed during this interval.
When experiments with nonbicarbonate buffers were performed, 10 Mmoles phosphate buffer per ml or 10
Amoles (with respect to Cl-) Tris-HCl per ml was substituted for bicarbonate. The flasks were gassed with 100% 02. Filter paper saturated with 6 N NaOH was present in the center well throughout the incubation so that evolved C02 was collected continuously. When bicarbonate plus phosphate or Tris buffer was used, the appropriate pH of the nonbicarbonate buffer for a given concentration of HCO3-was calculated with the Henderson-Hasselbalch equation and a pK of 6.10; an a-value of 0.0315; and a carbon dioxide pressure (Pco2) of 728 X (per cent C02 of the gas mixture), (728 = 760 mm Hg -water vapor pressure at 300 C). The other conditions of incubation were the same as those described for media buffered with bicarbonate alone.
In some experiments substrate utilization was determined by measuring the amount of organic acids remaining in the medium after incubation with the tissue slices. The same slicing and incubation procedure was followed as that described above, except that the incubation time was longer and the experiment was terminated by opening the flask and rapidly adding 2 ml of 20%o trichloroacetic acid (TCA). The slices and medium were then transferred to a Potter-Elvehjem homogenizer, and the slices were homogenized. The suspension was centrifuged and the supernatant saved for measurement of the organic acids. The term "citrate utilization" is used throughout the paper to describe results of experiments in which the amount of citrate remaining in the medium after incubation was measured. Citrate oxidation, on the other hand, is used to refer to experiments in which the conversion of radioactive citrate to 14CO2 was measured as described in the preceding paragraph.
In further experiments the total citrate content in slices and medium was compared in slices incubated with various combinations of bicarbonate and phosphate or Tris buffers. Citrate was omitted from the media so that substrate was provided entirely by pyruvate and malate. About 200 mg of slices was incubated in 1.8 ml of medium in each flask for 15 minutes. The incubation was stopped with 2 ml of 20% TCA. After homogenizing the slices and centrifuging, we removed the supernatant for citrate determination.
Preparation and incubation of mitochondria. Mitochondria were prepared by the short method of Lehninger (8) . Fresh rabbit kidneys were homogenized for 60 seconds in a Waring blendor in ice-cold 8.5% sucrose containing 0.001 M EDTA. pH was maintained during homogenization at about 7.0 by the dropwise addition of 6 N KOH. The homogenate was centrifuged at 00 C at 1,000 X g for 5 minutes and the sediment discarded. A sufficient amount of 1.5 M KC1 was added to the supernatant to bring the KCl concentration of the solution to 0.15 mole per L. The solution was allowed to stand for 10 minutes in an ice bucket and then centrifuged for 15 minutes at 00 C at 1,500 X g. The supernatant was discarded, and the mitochondrial pellet was resuspended in 0.15 N KC1 and centrifuged at the same speed for 10 minutes. This washing step was repeated once again. After the final wash, the mitochondrial pellet was suspended in about 5 ml of ice-cold 0.15 M KC1, providing a thick slurry of mitochondria.
We added 0.5 ml of the mitochondrial preparation to 1.5 ml of medium that had previously been equilibrated at 30°C with 5%o COr-95% 02 or another gas mixture in a Dixon-Keilin flask in a Warburg bath. A typical medium contained in each milliliter, after addition of the mitochondria, 10 gmoles KHCO3, 70 umoles KC1, 3 Amoles MgSO4, 10 Emoles phosphate buffer, 4 umoles Na4ATP, and 1 Amole K citrate. This composition does not include the KCl used to suspend the mitochondria.
In calculating the osmolarity of the final incubation solution we assumed that the mitochondrial suspension contained 80%o of 0.15 M KCl so that the total osmolarity of the medium after addition of the mitochondria was about 270 mOsm per L. We neutralized citrate and other organic acid solutions to pH 7.2 before preparing the medium. The ATP 1 solution was neutralized immediately before use and added to the rest of the medium just before the mitochondria were added. The proper pH of the phosphate buffer for a given concentration of HC03-was calculated in the same manner as described for the slice experiments. When changes in the composition of the medium were made, the concentration of KCl was adjusted to keep the osmolarity constant. The mitochondria were gassed and incubated in the same manner as the tissue slices except that the gassing time after introduction of the mitochondria was reduced to 3 minutes and the incubation time to 10 minutes.
In two experiments the total citrate content of mitochondria and medium was measured after incubation for 12 minutes with phosphate or bicarbonate buffers. Two Emoles pyruvate and malate per ml was used as substrate. The incubation was stopped with 3% perchloric acid; samples were assayed for citrate.
Analytical methods. In experiments in which radioactive citrate was used the NaOH solution in the center well of the Warburg flask was transferred quantitatively to a centrifuge tube. The filter paper was removed from the center well and washed carefully with water; the washings were added to the centrifuge tube. Carrier Na2CO3 was added and the carbonate precipitated with BaCl2. The precipitate was washed twice with water and placed in a planchet. After drying, planchets were counted in a gas flow proportional counter and the counts per minute corrected for self-absorption.
1 Sigma Chemical Co., St. Louis, Mo.
Citrate was determined by McArdle's modification of the pentabromacetone method (9) . Pyruvate was measured by the method of Friedemann and Haugen (10) in the tissue slice experiments with ethyl acetate as the extracting solvent, and by Huckabee's modification (11) of this method in the experiments on mitochondria. Alpha-ketoglutarate was measured by the method of Friedemann and Haugen (10) . Malate was determined fluorometrically (12) . Twenty-five-,gl samples of the tissue extract were used for the assay; under the conditions of these experiments it was not necessary to precipitate the malate with calcium as originally described.
In the Figures oxidation in heart and liver. Figure 3 shows the Figure  4 . In each experiment of this type, the lines representing the two different bicarbonate concentrations intersect at a point on the ordinate, indicating a competitive type of inhibition (13) . The maximal velocities (point of intersection on ordinate) in the two experiments were 75 ( Figure 4) and 50 mIumoles per minute.
Effect of variations in the components of the CO2-bicarbonate buffer system on citrate oxidation. Since both pH and [HCO3-] varied in the preceding experiments, the inhibitory effect on citrate oxidation could be related to the change in one or the other or both of these components of the buffer system. By varying the per cent CO2 in the gas phase with a constant [HCO1-] in the medium, pH was varied independently of [HCO,-] and a significant inhibitory effect on citrate oxidation was found ( Figure 5, a) . In five experiments of this type the mean slope obtained was Citrate content of mitochondria after incubation with bicarbonate and phosphate buffers. The results of one of two experiments in which citrate content was determined after incubating mitochondria with pyruvate and malate are shown in Table VII . The bicarbonate-buffered media contained 10 Emoles phosphate buffer of the appropriate pH in each milliliter; the composition of the phosphate-buffered media was similar, except that KCl replaced the KHCO5. In both experiments, as in similar experiments with slices, citrate content increased with increasing pH when mitochondria were incubated with a phosphate buffer. However, when bicarbonate was also present in the medium, the citrate content at each pH level was considerably increased, and the magnitude of the change in citrate content with increasing pH was enhanced by bicarbonate.
Effect of variations in the CO2-bicarbonate buffer system on citrate oxidation. In the tissue slice experiments it was found that the inhibitory effect was related to the change in pH of the medium rather than to the change in [HCO,-] ( Figure 5 and- Table V) . When similar experiments were repeated with mitochondria, the results were reversed. In this case, when pH was held constant and [HCO5-] and per cent CO2 varied, citrate oxidation decreased with increasing [HCO3-] (Figure 8, a) (13, 15) . Within a few minutes after induction of metabolic alkalosis, citrate clearance increases to many times the previous nonalkalotic value (1, 3) . At the same time little change in plasma citrate occurs. Consequently, the change in citrate excretion in metabolic alkalosis is due entirely to an alteration in the renal handling of citrate.
2) In metabolic alkalosis citrate concentration in kidney tissue increases (1) . When other organs are examined, no comparable change in citrate concentration occurs (16) . Also, the uptake and oxidation of extracellular citrate are unimpaired in organs other than the kidney (17) . Thus, the effect of metabolic alkalosis on the metabolism of extracellular citrate appears to be limited to the kidney.
3) Metabolic alkalosis also increases the clearance of a-ketoglutarate, and the properties of this effect are similar to those described for citrate (1, 18) . Comparable changes in pyruvate and malate clearances, however, have not been described (19, 20) . 4) Alkalinization of the urine in the absence of systemic alkalosis, as produced by acetazolamide administration, for instance, does not increase citrate clearance (1, 21, 22) . Induction of alkalosis in the presence of acetazolamide, however, leads to a prompt increase in citrate clearance (23) . Therefore, citrate clearance is not altered by a 'change in the pH or bicarbonate concentration of the tubular fluid alone. In potassium deficiency, where an intracellular acidosis and an extracellular alkalosis coexist (24, 25) , citrate clearance is not increased (19, 25, 26) . During recovery from potassium deficiency, citrate excretion increases as the intracellular acidosis is corrected. These facts suggest that the alteration in citrate clearance by metabolic alkalosis is related to the presence of an intracellular alkalosis and not to concomitant changes in the acid-base balance of the extracellular fluid or urine.
5) The effect of metabolic alkalosis on citrate clearance appears to be due principally to inhibition of citrate reabsorption rather than to stimulation of citrate secretion. The evidence for this is based on an experiment by Grollman, Harrison, and Harrison (4) . These investigators infused simultaneously bicarbonate and malate, which also increases citrate clearance substantially, in order to obtain a maximal citrate excretion. The two agents together resulted in a large increase in citrate clearance to levels that approximated but did not exceed the filtration rate of citrate. In addition to this evidence Gordon, using 14C-labeled citrate and acetate, has obtained data which suggest that most of the urinary citrate in metabolic alkalosis is derived directly from plasma citrate (27). However, these results do not entirely eliminate the possibility that metabolic alkalosis, in addition to inhibiting the reabsorption of citrate, also stimulates the secretion of some citrate synthesized in the renal tubules. Indeed, Runeberg and Lotspeich have recently reported that infusion of 14C-labeled succinate into one renal artery of an alkalotic dog results in the appearance in the urine of labeled citrate synthesized by the infused kidney (28) .
The results summarized above indicate that the presence of metabolic alkalosis within the cells of the renal tubules interferes with the reabsorption of citrate from the tubular fluid in a specific manner. We undertook the present study to investigate this phenomenon in an in vitro system. As pointed out in the introduction, this approach is feasible because citrate is removed from both the tubular fluid and the peritubular fluid and is oxidized within the cells of the renal cortex. After demonstrating inhibition of citrate oxidation in slices of renal cortex under conditions comparable to those in metabolic alkalosis, we studied the properties of this in vitro effect in order to compare it with the effect of metabolic alkalosis in the intact animal. These experiments show that in tissue slices: 1) increasing pH and bicarbonate concentration cause inhibition of citrate oxidation in kidney tissue but not in heart and liver when identical media are used for incubation of slices from the different organs; 2) citrate content is considerably increased in slices of The present study indicates that citrate clearance is increased in metabolic alkalosis because of an intracellular inhibitory effect of bicarbonate ion on citrate metabolism. Thus, under these circumstances, the rate of citrate excretion is regulated by the rate of intracellular oxidation of this substance in the cells of the nephron. Two hypotheses have been advanced previously to explain the inhibition of citrate reabsorption by metabolic alkalosis. Grollman and co-workers (4) speculated that alkalosis interferes with citrate transport across the cell membrane. Crawford, Milne, and Scribner (1), on the other hand, believed the effect was due to inhibition of the intracellular oxidation of citrate. These authors noted that the activity of condensing enzyme was markedly increased by increasing pH (29) . They suggested that in metabolic alkalosis more citrate is synthesized in cells of the renal tubules due to the enhanced activity of this enzyme. As a result, the intracellular concentration of citrate increases, and the rate of entry of extracellular citrate into the cell diminishes. The results of the present study suggest that Crawford and associates were correct in relating the effect of metabolic alkalosis on citrate clearance to intracellular inhibition of citrate oxidation rather than to an effect on the membrane transport of citrate. However, since their hypothesis does not provide a role for bicarbonate ion in the cause of this phenomenon, it is not an adequate explanation of the inhibitory mechanism.
Further investigation is necessary to provide insight into the biochemical mechanism by which bicarbonate influences the oxidation of extramitochondrial citrate. Few effects on metabolism are known to be caused by bicarbonate as an entity distinct from CO2. Bicarbonate may participate in some types of "CO2 fixation," but in general the molecular species involved in reactions concerning CO2 incorporation are undefined. Measurement of the extent of CO2 fixation in renal cortex, as well as definitive information on the molecular species involved, will be necessary before conclusions can be drawn on its relationship to the phenomenon under investigation. In attempting to find a biochemical explanation for the effect of bicarbonate on citrate oxidation, two points established in the present experiments are worth emphasizing. First, the inhibition of citrate oxidation is demonstrable in the absence of any substrate from the medium other than citrate itself. Second, this effect has the characteristics of competitive inhibition, suggesting that bicarbonate stimulates the entry of some substance into the Krebs cycle that competes with extramitochondrial citrate for entry into the cycle. These points may be helpful in formulating further experiments to define the cause of this effect.
